The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1192
September 20, 2004
View Complete Issue         Table of Contents 2019 
Issue 1192
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Generic Levothyroxine
September 20, 2004 (Issue: 1192)
The FDA has determined that 3 generic formulations of levothyroxine are therapeutically equivalent to brand-name formulations. Some brand-name manufacturers have objected, and endocrine organizations have expressed their concern.See levothyroxine...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1192
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.